Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying ...

Patrick Reilly, Eldin Hasic and Nikolas Spilson of Faegre Drinker discuss the European Union's new product liability ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

Officials met Hamas three times, breaking with a policy against contacting a group the U.S. considers a terrorist ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Marvel Rivals is bringing some changes to competitive play with the Season 2 update. Here’s everything you need to know ahead ...

On April 2, 2025, the U.S. Army xTech Program launched xTechOverwatch to advance military capabilities in autonomous air and ...

The Environmental Protection Agency has been trying to eliminate the use of septic tanks in coastal areas in an attempt to limit contamination. Panama City's commission approved another step in their ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

As developers continue to search for better amyotrophic lateral sclerosis (ALS) therapies, Neurosense Therapeutics Ltd. turned up some hopeful findings from its phase IIb Paradigm trial with PrimeC.

The Apple Vision Pro 2 headset may be arriving soon according to new manufacturing changes. The news comes that has moved into the mass production phase for its headset. Reports suggest that key ...